Search

Author/Creator Masuda, Norikazu

1. A multicenter phase II trial of neoadjuvant letrozole plus low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer (JBCRG‐07): therapeutic efficacy and clinical implications of circulating endothelial cells. (7th May 2018)

Authors:
Ueno, Takayuki; Masuda, Norikazu; Kamigaki, Shunji; Morimoto, Takashi; Akiyama, Futoshi; Kurosumi, Masafumi; Tsuda, Hitoshi; Mikami, Yoshiki; Tanaka, Sunao; Morita, Satoshi; Toi, Masakazu
Journal:
Cancer medicine
Issue:
Volume 7:Number 6(2018:Jun.)
Page Start:
2442
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes. (March 2019)

Authors:
Yonemori, Kan; Shimomura, Akihiko; Yasojima, Hiroyuki; Masuda, Norikazu; Aogi, Kenjiro; Takahashi, Masato; Naito, Yoichi; Shimizu, Satoru; Nakamura, Rikiya; Hashimoto, Jun; Yamamoto, Harukaze; Hirakawa, Akihiro; Michimae, Hirofumi; Hamada, Akinobu; Yoshida, Teruhiko; Sukigara, Tamie; Tamura, Kenj...
Journal:
European journal of cancer
Issue:
Volume 109(2019)
Page Start:
84
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study. (18th July 2018)

Authors:
Yamamoto, Yutaka; Iwata, Hiroji; Ueno, Takayuki; Taira, Naruto; Kashiwaba, Masahiro; Takahashi, Masato; Tada, Hiroshi; Tsugawa, Koichiro; Toyama, Tatsuya; Niikura, Naoki; Hara, Fumikata; Fujisawa, Tomomi; Yoshinami, Tetsuhiro; Saji, Shigehira; Takano, Toshimi; Masuda, Norikazu; Morita, Satoshi; T...
Journal:
Japanese journal of clinical oncology
Issue:
Volume 48:Number 9(2018)
Page Start:
855
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials. Issue 6 (1st May 2021)

Authors:
Toi, Masakazu; Inoue, Kenichi; Masuda, Norikazu; Iwata, Hiroji; Sohn, Joohyuk; Hae Park, In; Im, Seock‐Ah; Chen, Shin‐Cheh; Enatsu, Sotaro; Turner, P. Kellie; André, Valérie A. M.; Hardebeck, Molly C.; Sakaguchi, Sachi; Goetz, Matthew P.; Sledge, George W.
Journal:
Cancer science
Issue:
Volume 112:Issue 6(2021)
Page Start:
2381
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 1 (January 2021)

Authors:
Toi, Masakazu; Imoto, Shigeru; Ishida, Takanori; Ito, Yoshinori; Iwata, Hiroji; Masuda, Norikazu; Mukai, Hirofumi; Saji, Shigehira; Shimizu, Akira; Ikeda, Takafumi; Haga, Hironori; Saeki, Toshiaki; Aogi, Kenjiro; Sugie, Tomoharu; Ueno, Takayuki; Kinoshita, Takayuki; Kai, Yuichiro; Kitada, Masahir...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 1(2021)
Page Start:
74
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Analysis of Ki‐67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer 1. Issue 4 (12th September 2012)

Authors:
Iwata, Hiroji; Masuda, Norikazu; Sagara, Yasuaki; Kinoshita, Takayuki; Nakamura, Seigo; Yanagita, Yasuhiro; Nishimura, Reiki; Iwase, Hirotaka; Kamigaki, Shunji; Takei, Hiroyuki; Tsuda, Hitoshi; Hayashi, Nobuya; Noguchi, Shinzaburo
Journal:
Cancer
Issue:
Volume 119:Issue 4(2013)
Page Start:
704
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation. (January 2017)

Authors:
Miles, David; Cameron, David; Bondarenko, Igor; Manzyuk, Lyudmila; Alcedo, Juan Carlos; Lopez, Roberto Ivan; Im, Seock-Ah; Canon, Jean-Luc; Shparyk, Yaroslav; Yardley, Denise A.; Masuda, Norikazu; Ro, Jungsil; Denduluri, Neelima; Hubeaux, Stanislas; Quah, Cheng; Bais, Carlos; O'Shaughnessy, Joyce
Journal:
European journal of cancer
Issue:
Volume 70(2017)
Page Start:
146
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2. (November 2018)

Authors:
Campone, Mario; Im, Seock-Ah; Iwata, Hiroji; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiełło-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Cortés, Javier; De Laurentiis, Michele; Arteaga, Carlos L.; Jiang, Zefei; Jonat, Walter; Le...
Journal:
European journal of cancer
Issue:
Volume 103(2018)
Page Start:
147
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2017)

Authors:
Baselga, José; Im, Seock-Ah; Iwata, Hiroji; Cortés, Javier; De Laurentiis, Michele; Jiang, Zefei; Arteaga, Carlos L; Jonat, Walter; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiełło-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Taka...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 7(2017:Jul.)
Page Start:
904
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. Issue 1 (27th February 2019)

Authors:
Ueno, Takayuki; Saji, Shigehira; Masuda, Norikazu; Iwata, Hiroji; Kuroi, Katsumasa; Sato, Nobuaki; Takei, Hiroyuki; Yamamoto, Yutaka; Ohno, Shinji; Yamashita, Hiroko; Hisamatsu, Kazufumi; Aogi, Kenjiro; Sasano, Hironobu; Toi, Masakazu
Journal:
ESMO open
Issue:
Volume 4:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗